@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

nalt:148713
  skos:definition nalt:148713_def ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2011-10-04"^^xsd:date ;
  skos:broader nalt:10191, nalt:148701 ;
  ns0:marc001 "59919" ;
  skos:prefLabel "moxalactam"@es, "moxalactam"@en ;
  dc:modified "2012-11-30"^^xsd:date ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> .

nalt:148713_def
  rdf:value "Antibiótico beta-lactámico de amplio-espectro, similar en estructura a las cefalosporinas, excepto por la sustitución de medio oxa azabiciclo por medio tia azabiciclo de ciertas cefalosporinas . Se ha propuesto especialmente para la meningitidis (meningococo) porque atraviesa la barrera sangre-cerebro y combate las infecciones anaeróbicas."@es, "Broad- spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain cephalosporins. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections."@en ;
  dc:source "Medical Subject Headings 2011" ;
  a ns0:Definition .

nalt:10191
  skos:prefLabel "antibióticos beta-lactámicos"@es, "beta-lactam antibiotics"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:148713 .

ns0:Chemical
  rdfs:label "Chemical"@en ;
  a owl:Class .

nalt:148701
  skos:prefLabel "beta-lactamas"@es, "beta-lactams"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:148713 .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .